Overview

This trial is active, not recruiting.

Condition

diabetes

Sponsor

Assistance Publique - Hôpitaux de Paris

Start date

December 2012

End date

December 2016

Trial size

17 participants

Trial identifier

NCT02072551, GLUCONEO

Summary

The main objective of this study is to evaluate Beta cells in patients with a neonotal
diabetes linked to a genetic abnormality Metabolic caracteristics will described using a
transversal cohort study.